Caution Advised In China’s Digital Dash Into Healthcare’s Future

China’s digital healthcare market is set to expand massively and reach $110bn by 2020, disrupting the industry, creating fresh opportunities and casting aside those who don’t keep up with the times. However, experts caution that digital solutions are no panacea unless they have real patient-centered value.

TAIPEI – Going digital for the sake of it is not going to work in China, analysts caution, despite a wealth of evidence suggesting the digital healthcare market is set to make huge gains over the next five years. Rather, a clear-cut strategy is required that provides real value to patients.

In a report released in mid-September, the Boston Consulting Group said that digital healthcare services in China have not only...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Focus On Asia

Sino Biopharm Scoops LaNova In Chinese Pharma’s Biggest Biotech Buyout So Far

 

Sino Biopharm will pay almost $1bn to acquire what target LaNova’s CEO described as an “exploding” pipeline, which includes six clinical-stage candidates in the oncology area.

China Sentences Astellas Employee To 3.5 Years In Prison On Spy Charges

 
• By 

An employee of Astellas faces three and a half years in prison after sentencing by a court in China on espionage charges.

Sun’s Alopecia Treatment Debuts In US - Can It Make Up For Lost Time?

 

Sun’s Leqselvi goes up against Lilly's Olumiant and Pfizer's Litfulo, which currently has the broadest label, in the US alopecia market. Can it shake things up early, amid growing activity in the space with several new mechanisms of action being investigated?